Fisetin and Alzheimer's Disease: What the Clinical Data Shows
Expert Summary
Fisetin crosses the blood-brain barrier and reduces neuroinflammation, tau hyperphosphorylation, and amyloid-beta plaque formation in multiple Alzheimer's disease animal models. The Alzheimer's Research Association-funded MEND-AD trial is currently evaluating fisetin in human subjects with mild cognitive impairment.
Key Facts
- Blood-brain barrier penetration: Unlike many flavonoids, fisetin demonstrates measurable CNS accumulation. PK studies in rodents confirm fisetin and its metabolites reach hippocampal and cortical tissue within 2 hours of oral dosing.
- Tau modulation: Fisetin reduces aberrant tau phosphorylation at key Alzheimer's-relevant epitopes (Ser202/Thr205, Thr231) by inhibiting CDK5 and GSK-3β, two kinases central to tau pathology.
- Amyloid-beta: In APP/PS1 transgenic mice, fisetin supplementation reduced amyloid-beta plaque density and improved spatial memory performance in Morris water maze testing.
- Neuroinflammation: Fisetin potently inhibits microglial activation and reduces NLRP3 inflammasome activity, a key driver of neuroinflammation in Alzheimer's disease.
- Brain senescence: Senescent astrocytes and microglia (characterized by p16 and p21 expression) accumulate in aging brains and contribute to Alzheimer's pathology. Fisetin's senolytic activity may clear these problematic cells.
- MEND-AD trial: NCT02956577 evaluated fisetin in individuals with Alzheimer's disease. Preliminary reports suggest improvements in oxidative stress markers and no significant adverse events.
Recommended Products
Frequently Asked Questions
Can fisetin prevent Alzheimer's disease?
Current evidence is preclinical. Fisetin cannot be claimed to prevent or treat Alzheimer's. However, its multi-target mechanisms (senolytic, anti-tau, anti-amyloid, anti-inflammatory) make it a promising preventive candidate in high-risk populations.
What dose is used for brain health?
For neuroprotection, lower continuous doses (100–200 mg/day) are used by some practitioners in addition to periodic burst dosing (20 mg/kg, 2 days). Human trial data for specific neuroprotective doses is still emerging.
Should people with Alzheimer's family history take fisetin?
Given its safety profile and multi-mechanism brain protection, many longevity practitioners recommend fisetin for those with APOE4 genotype or Alzheimer's family history. This is an individual decision best made with a healthcare provider.
Scientific References
- Maher P. Modulation of multiple pathways involved in the maintenance of neuronal function by fisetin. Genes & Nutrition. 2009. PMID: 18726694
- Currais A et al. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function. Aging Cell. 2014. PMID: 24329923